Watchlist Price Alert

Kazia Therapeutics Limite... (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

9.24

0.19 (2.10%)

At close: Jun 17, 2025, 3:59 PM

9.27

0.32%

After-hours: Jun 17, 2025, 07:57 PM EDT

Kazia Therapeutics Balance Sheet Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016	Dec 31, 2015
Cash & Equivalents	1.66M	3.56M	5.24M	4.39M	7.36M	15.19M	27.59M	19.37M	8.76M	6.44M	5.43M	5.41M	5.96M	6.64M	14.46M	18.6M	33.45M	37.63M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	168K	2.75M	4.33M	7.8M	22K	13.96K	13K	15.37K
Other Long-Term Assets	40K	40K	42.92K	3.72M	7.3M	6.93M	6.69M	7.17M	n/a	-12.95M	-13.66M	-16.79M	-18.92M	-23.06M	-16.43M	-20.52M	-1.43M	-1.74M
Receivables	133K	n/a	610.00	700.97K	n/a	n/a	n/a	n/a	439.00	n/a	n/a	n/a	1.13K	202.27K	5.07K	374.37K	91K	246.15K
Inventory	n/a	n/a	-105.03K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	434K	n/a
Other Current Assets	n/a	n/a	3.9M	n/a	90.97K	n/a	84.36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.44M	n/a	2.87M
Total Current Assets	6.14M	8.01M	10.77M	5.92M	9.45M	16.71M	29.39M	20.58M	10.65M	7.55M	7.51M	8.81M	9.26M	14.75M	19.48M	24.73M	34.09M	41.12M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	147.2K	490K	551.25K	592K	614.01K
Goodwill & Intangibles	15.4M	16.33M	17.27M	18.2M	19.14M	21.03M	22M	11.87M	12.41M	12.95M	13.49M	14.04M	14.58M	15.12M	15.92M	19.95M	822K	1.11M
Total Long-Term Assets	15.44M	16.37M	17.31M	21.92M	26.44M	27.96M	28.7M	19.04M	12.41M	12.95M	13.66M	16.79M	18.91M	23.06M	16.43M	20.52M	1.43M	1.74M
Total Assets	21.59M	24.38M	28.09M	27.84M	35.89M	44.67M	58.09M	39.61M	23.06M	20.5M	21.18M	25.6M	28.18M	37.82M	35.91M	45.25M	35.52M	42.86M
Account Payables	4.55M	1.04M	857K	2.31M	1.52M	2.35M	1.89M	2.52M	1.69M	2.94M	1.05M	2.29M	1.41M	2.78M	1.25M	2.37M	512K	1.43M
Deferred Revenue	n/a	n/a	4.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	138K	183.82K	41K	n/a	900K	n/a
Short-Term Debt	634K	359.3K	1.8M	552.32K	1.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	10.1M	4.65M	750K	1.44M	758.84K	779.91K	3.16M	n/a	1.58M	n/a	n/a	133.45K	1.68M	4.04M	3.47M	n/a	132K	n/a
Total Current Liabilities	25.8M	11.34M	7.57M	5.58M	6.73M	7.59M	8.33M	2.72M	5.07M	3.09M	1.9M	2.43M	3.89M	7.06M	5.38M	2.52M	1.43M	1.52M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.79M	7.78M	8.47M	10.67M	10.89M	11.58M	11.91M	5.22M	458K	5.15M	5.08M	4.8M	1.04M	4.99M	874K	11.09M	154K	152.73K
Total Long-Term Liabilities	5.8M	7.78M	8.47M	10.67M	-368	11.58M	-484	5.22M	3.87M	5.15M	5.08M	4.8M	5.05M	4.99M	5.19M	11.09M	154K	152.73K
Total Liabilities	31.6M	19.12M	16.03M	16.25M	6.73M	19.18M	8.33M	7.94M	8.94M	8.24M	6.98M	7.23M	8.93M	12.04M	10.57M	13.61M	1.59M	1.67M
Total Debt	634K	359.3K	1.8M	552.32K	1.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	84K	n/a	10K	n/a	10K	n/a
Common Stock	101.64M	98.78M	97.45M	90.34M	84.48M	80.31M	80.29M	72.39M	48.78M	40.38M	36.64M	36.64M	31.58M	31.58M	193.77M	193.77M	191.3M	191.3M
Retained Earnings	-115.13M	-97.91M	-89.08M	-82.2M	-68.62M	-56.63M	-44.2M	-42.22M	-36.19M	-30.83M	-24.95M	-20.71M	-14.64M	-8.31M	-170.96M	-164.47M	-160.51M	-152.28M
Comprehensive Income	3.48M	4.39M	-741.79K	3.44M	2.41M	1.35M	1.76M	1.05M	1.07M	-451.85K	2.04M	1.97M	1.84M	2.05M	1.93M	1.75M	1.42M	770.15K
Shareholders Equity	-10.02M	5.27M	12.05M	11.58M	18.27M	25.49M	37.85M	31.68M	14.13M	12.26M	14.2M	18.37M	19.24M	25.77M	25.34M	31.64M	33.93M	41.51M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	168K	2.75M	4.33M	7.8M	22K	13.96K	13K	15.37K